In the last years, major progress occurred in heart failure (HF) management. Quadruple
therapy is now mandatory for all the patients with HF with reduced ejection fraction. Whilst …

Heart failure (HF) is a major cause of mortality, hospitalizations, and reduced quality of life
and a major burden for the healthcare system. The number of patients that progress to an …

Major changes have occurred in these last years in heart failure (HF) management.
Landmark trials and the 2021 European Society of Cardiology guidelines for the diagnosis …

Objective To determine the impact of sodium-dependent glucose type 2 cotransporter
inhibitors on the renal function in acute heart failure. Methods In a single-centre, controlled …

Acute heart failure (AHF) represents a common clinical scenario that requires prompt
evaluation and therapy and that is characterized by a high risk of mortality or subsequent …

In the last years, major progress has occurred in heart failure (HF) management. The 2023
ESC focused update of the 2021 HF guidelines introduced new key recommendations …

Background The incidence of heart failure (HF) is increasing year by year, posing a great
threat to human health. Although pharmacotherapy has been able to significantly prolong …

OBJECTIVE: This meta-analysis was performed to evaluate the diagnostic efficacy of lung
ultrasound (LUS) in cardiogenic pulmonary edema. MATERIALS AND METHODS: An …

Prevalence of heart failure is increasing worldwide mainly due to the ageing of the
population and the improvement in diagnosis and treatment. In recent years, huge progress …

Background Chronic heart failure (CHF) is a cardiovascular disease that seriously
jeopardizes global human health. Studies indicate that good self-management can be …